Meril Italy v Edwards Lifesciences (CFI, 23 September 2024)
| Date | 23 September 2024 |
|---|---|
| Court | CFI |
| Division | Paris (FR) Central Division - Seat |
| Type of action | Application RoP262.1 (b) |
| Registry reference | App_33484/2024 · ORD_36092/2024 |
| Parties | KIPA AB |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 23 September 2024 (UPC_CFI_189/2024, ACT_22275/2024, App_33484/2024, ORD_36092/2024), the judge-rapporteur of panel 2 of the Paris Central Division (P. Catallozzi) refused a request for access to all written pleadings and evidence in the action for revocation of EP 4 151 181 brought by Meril Italy srl, Meril GmbH and Meril Life Sciences Pvt Ltd against Edwards Lifesciences Corporation. The request came from SWAT Medical AB and an individual describing himself as a board member and investor. The order makes clear that the interest relied on by a third party must be shown, not merely asserted.
Question
Can a third party claiming to be a competitor with an interest in the patent’s validity obtain access, under Rule 262.1(b), to the pleadings and evidence of pending proceedings?
Decision
Openness is the principle (Art. 10(1) and Art. 45 UPCA), subject to a balancing against the interests of the parties and third parties, the integrity of the proceedings and public order (paragraphs 8 to 11). The applicant must state the purpose of the request and why the documents are needed (paragraph 12). A competitor or licensee may have a direct interest in validity, including while proceedings are pending (paragraph 13), but being active in the same field is not enough: the applicant had not shown that it competed with the parties (paragraphs 14 and 15). A general interest in information does not outweigh the protection of the integrity of the pending proceedings (paragraphs 16 and 17), nor the protection of personal interests (paragraph 18).
Key points for practice
- Practical point: a third party relying on its status as a competitor must substantiate it, while proceedings are pending, a general interest in information yields to their integrity.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 10(1) and Art. 45
- Rules of Procedure
- Rule 262.1(b)
- Case law cited
- Ocado Innovation v Autostore, Court of Appeal, 10 April 2024, Vienna Local Division, 12 August 2024, UPC_CFI_33/2024, Nordic-Baltic Regional Division, 17 September 2024, UPC_CFI_8/2023
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Confidentiality club.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantKIPA AB8 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Application RoP262.1 (b)
- Outcome (Dhenne Avocats summary)
- La demande d'accès aux écritures et pièces est rejetée : la qualité de concurrent n'est pas établie et l'intérêt général d'information ne l'emporte pas sur l'intégrité de la procédure en cours.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 4 151 181mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Ocado Innovation v Autostore (CoA, 10 April 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 4 151 181 | Mentioned in the analysis (role not qualified) Also mentioned in 4 other decision(s): Meril Life Sciences v Edwards Lifesciences (CFI, 20 October 2025) · Meril Italy v SWAT Medical (CFI, 8 January 2025) · Edwards Lifesciences v Meril Life Sciences (CFI, 8 October 2024) · Meril Life Sciences v Edwards Lifesciences (CFI, 17 September 2024) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.